<code id='214BE1E4AC'></code><style id='214BE1E4AC'></style>

<acronym id='214BE1E4AC'></acronym>

<center id='214BE1E4AC'><center id='214BE1E4AC'><tfoot id='214BE1E4AC'></tfoot></center><abbr id='214BE1E4AC'><dir id='214BE1E4AC'><tfoot id='214BE1E4AC'></tfoot><noframes id='214BE1E4AC'>

<optgroup id='214BE1E4AC'><strike id='214BE1E4AC'><sup id='214BE1E4AC'></sup></strike><code id='214BE1E4AC'></code></optgroup>

<b id='214BE1E4AC'><label id='214BE1E4AC'><select id='214BE1E4AC'><dt id='214BE1E4AC'><span id='214BE1E4AC'></span></dt></select></label></b><u id='214BE1E4AC'></u>

~~<i id='214BE1E4AC'><strike id='214BE1E4AC'><tt id='214BE1E4AC'><pre id='214BE1E4AC'></pre></tt></strike></i>~~

Home» Wikipedia» focus

focus

focus

author：fashion 2025-09-27 07:27:50 Page View：6221

Pharmacy shelves — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Artificial intelligence advances fuel industry trying to preserve loved ones after death
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

explore

Activists slam private health insurers over coverage restrictions

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Pfizer plans to depart BIO

Pfizer plans to depart BIO

Pfizerplanstoexitamajorbiotechnologyindustrytradeassociation.CindyOrd/GettyImagesforPfizer/BioNTechW

As demand for Covid shots wanes, Moderna seeks its next success

As demand for Covid shots wanes, Moderna seeks its next success

RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

A double vaccine crisis is endangering millions of children

AdobeWorldhealthexpertsmetrecentlytodiscussanemergingglobalhealthcrisislinkedtotheCovid-19pandemic:p

read more